Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-261777
Filing Date
2024-11-19
Accepted
2024-11-19 16:43:55
Documents
3
Period of Report
2024-11-19

Document Format Files

Seq Description Document Type Size
1 6-K d862454d6k.htm 6-K 12814
2 EX-99.1 d862454dex991.htm EX-99.1 25556
3 GRAPHIC g862454g1119030548984.jpg GRAPHIC 2757
  Complete submission text file 0001193125-24-261777.txt   43324
Mailing Address 7 BD HAUSSMANN PARIS I0 75009
Business Address 7 BD HAUSSMANN PARIS I0 75009 01 53 83 09 63
Abivax S.A. (Filer) CIK: 0001956827 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41842 | Film No.: 241476867
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)